Dachaigh › Siostam Immune agus Galaran › Ohio
Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an Ohio
Tha 9 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann an Ohio.
Bailtean ann an Ohio
Teacsa sgrùdaidh oifigeil (Beurla)
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Strecker Cancer Center-Belpre, Belpre
- Miami Valley Hospital South, Centerville
- Adena Regional Medical Center, Chillicothe
- agus 26 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04242095A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University Hospitals Cleveland Medical Center, Cleveland
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
- Cleveland Clinic, Cleveland
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535Abatacept for the Treatment of Giant Cell Arteritis
- Cleveland Clinic, Cleveland
A’ fastadhÌre 3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT04474847A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07037901CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Cleveland Clinic, Cleveland
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Cleveland Clinic, Cleveland
- The Ohio State University Comprehensive Cancer Center, Columbus
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dùbh 2025 · NCT06619561Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.